On October 23, 2025, Avantor, Inc. announced a collaboration agreement with p‑Chip Corporation to co‑develop a new generation of "Smart Consumables" that embed p‑Chip's microtransponder technology into laboratory and clinical consumables. The partnership will embed a durable microtransponder with a unique, secure identifier into vials, slides, cassettes, tubes and plates, enabling end‑to‑end traceability and automated process control for chain‑of‑identity (COI) compliance.
Corey Walker, President of Avantor’s Laboratory Solutions segment, said the innovation supports Avantor’s mission to enable scientific breakthroughs and meets high‑value customer needs in personalized medicine. Michael Hadjisavas, COO of p‑Chip, highlighted that the microtransponder platform will play a pivotal role in advancing traceability and compliance in lab workflows, streamlining quality control and accelerating digital transformation in pharmaceutical and healthcare processes.
The Smart Consumables line represents a strategic shift toward digitally enabled lab solutions, positioning Avantor to capture the growing demand for precision therapies that require secure sample identification and monitoring. By embedding digital intelligence directly into consumables, Avantor expands its differentiated technology portfolio and strengthens its competitive moat in the life‑sciences market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.